Key FDA decisions and pivotal late-stage obesity and breast cancer data could reshape competitive positioning
DBT-BIRAC, BioE3 and the Rs 10,000-crore Biopharma SHAKTI scheme aim to accelerate innovation, biomanufacturing and exports
A joint position paper warns that Europe is the only major global region without a dedicated biomanufacturing initiative
She brings 20 years of in vivo pharmacology experience across academia and industry, including senior scientific and leadership roles at Orion Pharma and Charles River
The showcase, running March 27–31, puts a spotlight on everything from fine lines to daily sun protection
The US FDA has approved PONLIMSI (denosumab-adet) as a biosimilar to Prolia
Kedar Upadhye has also been appointed as Chief Financial Officer of Biocon Limited
Targets diabetes & obesity crisis as India grapples with soaring metabolic disorders
India’s largest glycolic acid manufacturer will unveil AviGa Bio HP70 on April 14, 2026
RSM01, a preventive treatment targeting respiratory syncytial virus (RSV), was licensed earlier this month from the Gates Medical Research Institute
Subscribe To Our Newsletter & Stay Updated
